EQUINOX NEPREMICNINE d.d. (LJSE:EQNX)
64.00
0.00 (0.00%)
At close: Jun 4, 2026
EQUINOX NEPREMICNINE d.d. Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Property, Plant & Equipment | 32.06 | 31.55 | 33.74 | 36.57 | 40.17 | 37.79 |
Cash & Equivalents | 0.47 | 0.15 | 0.35 | 3.65 | 10.81 | 6.7 |
Accounts Receivable | 1.3 | 1.35 | 1.04 | 0.61 | 0.27 | 0.29 |
Other Receivables | - | 0.01 | 0.01 | - | - | - |
Investment In Debt and Equity Securities | 23.76 | 22.8 | 15.78 | 12.03 | 8.69 | 9.72 |
Other Intangible Assets | 0 | 0 | 0.01 | 0.01 | 0.04 | 0.08 |
Other Current Assets | 0.02 | 0.01 | 0 | 0 | 0 | 0.34 |
Deferred Long-Term Tax Assets | - | - | - | 0.09 | 0.05 | 0.12 |
Other Long-Term Assets | 0.01 | 0.01 | 0.46 | 0.31 | 0 | 0.01 |
Total Assets | 57.63 | 55.88 | 51.4 | 53.28 | 60.03 | 55.04 |
Current Portion of Long-Term Debt | 0.78 | 1 | 0.66 | 0.71 | 5.75 | 0.55 |
Long-Term Debt | 10.45 | 9.57 | 7.52 | 8.18 | 8.84 | 13.44 |
Accounts Payable | 0.37 | 0.32 | 0.34 | 0.28 | 0.17 | 0.22 |
Accrued Expenses | - | 0.13 | - | 0.11 | 0.13 | 0.52 |
Current Income Taxes Payable | - | 0.68 | 0.06 | 0.09 | - | - |
Other Current Liabilities | 1.13 | 0.12 | 0.38 | 0.18 | 0.17 | - |
Long-Term Unearned Revenue | 0.19 | 0.19 | 0.21 | 0.25 | 0.08 | 0.14 |
Long-Term Deferred Tax Liabilities | 0.76 | 0.78 | 0.41 | - | - | - |
Other Long-Term Liabilities | 3.62 | 3.62 | 3.87 | 3.66 | 3.63 | 0.1 |
Total Liabilities | 17.31 | 16.39 | 13.45 | 13.45 | 18.76 | 14.98 |
Common Stock | 5.69 | 5.69 | 5.69 | 5.69 | 5.69 | 5.69 |
Additional Paid-In Capital | - | - | - | 1.21 | - | - |
Retained Earnings | 17.36 | 16.96 | 16.59 | 18.33 | 20.02 | 19.31 |
Treasury Stock | -0.51 | -0.49 | -0.37 | -0.15 | - | - |
Comprehensive Income & Other | 17.79 | 17.32 | 16.03 | 14.76 | 15.55 | 15.06 |
Shareholders' Equity | 40.33 | 39.49 | 37.95 | 39.83 | 41.26 | 40.06 |
Total Liabilities & Equity | 57.63 | 55.88 | 51.4 | 53.28 | 60.03 | 55.04 |
Total Debt | 11.23 | 10.56 | 8.18 | 8.89 | 14.6 | 14 |
Net Cash (Debt) | -10.76 | -10.41 | -7.83 | -5.23 | -3.79 | -7.3 |
Net Cash Per Share | -6.03 | -5.83 | -4.39 | -2.89 | -2.13 | - |
Filing Date Shares Outstanding | 1.78 | 1.78 | 1.79 | 1.79 | 1.79 | 1.79 |
Total Common Shares Outstanding | 1.78 | 1.78 | 1.79 | 1.79 | 1.79 | 1.79 |
Book Value Per Share | 22.60 | 22.12 | 21.24 | 22.24 | 23.00 | 22.33 |
Tangible Book Value | 40.33 | 39.48 | 37.94 | 39.82 | 41.22 | 39.98 |
Tangible Book Value Per Share | 22.60 | 22.12 | 21.23 | 22.24 | 22.98 | 22.29 |
Land | - | 4.28 | 4.28 | - | - | - |
Buildings | - | 72.02 | 77.51 | 81.45 | 1.17 | 1.17 |
Construction In Progress | - | 0.87 | 0.34 | 1.03 | 0.14 | - |